Wladimir Bocca Vieira de Rezende Pinto

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Myasthenia Gravis and COVID-19: Clinical Characteristics and Outcomes

Antônio Edvan Camelo-Filho, André Macedo Serafim da Silva, Eduardo de Paula Estephan et al. · Frontiers in Neurology · 2020 · 105 citations · Full text

Autoimmune Disease, Intensive Care Unit, Immunodeficiencies +13

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Methylation pattern at the KvDMR in a child with Beckwith–Wiedemann syndrome conceived by ICSI

M.V. Gomes, Carolina Cavaliéri Gomes, Wladimir Bocca Vieira de Rezende Pinto et al. · American Journal of Medical Genetics Part A · 2007 · 45 citations

Epigenetic Change, Genetics, Genomic Imprinting +18

Clinical and radiological profile of patients with spinal muscular atrophy type 4

Paulo Victor Sgobbi de Souza, Wladimir Bocca Vieira de Rezende Pinto, Aracelly R.F. Ricarte et al. · European Journal of Neurology · 2020 · 44 citations